A possible explanation for this discrepancy may be that during tumor progression, as a means of immune escape mechanism, carcinogenic epithelial cells increase expression of FIBCD1 to induce a pro-tumor microenvironment characterized by increased local immune suppression that favors cancer growth and metastasis (3). The gene discussed is FIBCD1; the disease is neoplasm.